We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




New Design for Combat Tourniquet

By HospiMedica staff writers
Posted on 10 Jul 2006
A new tourniquet has been developed to replace the traditional cravat-and-stick tourniquet and the strap-and-buckle tourniquet that date back to the American Civil War.

The combat application tourniquet (CAT), manufactured by Phil Durango (Golden, CO, USA), is a one-handed tourniquet that completely occludes arterial and venous blood flow of an extremity in the event of a traumatic wound with significant hemorrhage. More...
The tourniquet uses a self-adhering band and a friction adaptor buckle to fit a wide range of extremities, combined with a one-handed windlass system with a free moving internal band to provide true circumferential pressure to the extremity. Once the band is tightened and the bleeding has stopped, the windlass is locked in place. A Velcro strap is then applied for further securing of the windlass during casualty evacuation.

The CAT was tested along with eight other tourniquets in 2004 at the U.S. Army Institute of Surgical Research (USAISR, San Antonio, TX, USA). The evaluation was prompted because many deploying soldiers and units were purchasing tourniquets on the Internet, but the tourniquets' effectiveness had not been determined. Once testing was complete, the institute's researchers recommended the CAT tourniquet as the first choice for issue to every soldier.

Tourniquets are being used on almost every extremity injury, and they are saving lives, said Colonel John B. Holcomb, a trauma consultant for the U.S. Surgeon General and commander of the USAISR, who was recently deployed as a surgeon at the 10th Combat Support Hospital in Iraq. Tourniquets were rarely seen early in the war, and now it's abnormal to see a severe extremity injury without a functional tourniquet in place. There is no pre-hospital device deployed in this war that has saved more lives than tourniquets.



Related Links:
Phil Durango
U.S. Army Institute of Surgical Research

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Absorbable Monofilament Mesh
Phasix Mesh
Electric Bed
DIXION Intensive Care Bed
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.